Nonetheless, caution should be exercised when using metformin in different patient populations who may be more susceptible to hypoglycemia, such as individuals with diabetes who are receiving insulin or sulfonylurea and/or those with renal and hepatic impairment. The gene discussed is INS; the disease is diabetes mellitus.